Swiss Life Sciences Stock News

Why the new SEK-SGP4x kit matters for Sensirion Holding stock Sensirion Holding (SWX:SENS) has released its SEK-SGP4x Evaluation Kit to the broader market, giving engineers simpler access to its VOC and NOx gas sensors for indoor air quality projects. The kit targets developers who want direct sensor data, compatibility with platforms like Arduino, and integration with Sensirion’s existing tools. Together, these features could influence how investors think about the company’s sensor...

As geopolitical tensions and energy market volatility weigh on European equities, the pan-European STOXX Europe 600 Index has experienced a notable decline. Amidst these market dynamics, dividend stocks can offer investors a measure of stability and income potential, making them an attractive option in uncertain times.

As geopolitical tensions and energy market volatility shape the European financial landscape, investors are closely monitoring how these factors influence inflation and monetary policy expectations. Amidst this backdrop, growth companies with high insider ownership can offer unique insights into potential resilience and strategic alignment with shareholder interests.

Amidst geopolitical tensions and economic uncertainties, European markets have faced a challenging environment, with the STOXX Europe 600 Index experiencing a decline of 1.79% recently. In this context, identifying growth companies with high insider ownership can be particularly appealing to investors seeking resilience and potential upside in volatile conditions.

A “super” El Niño expected in 2026–27 could rattle food supplies, push key crop prices sharply higher, and keep inflation pressure in play for years. For investors, that kind of shock can hurt some stocks tied to food and commodities while creating openings in others that are better positioned for price spikes and volatility. This article looks at three stocks that are closely exposed to the El Niño news, with one that could benefit from the setup and two where the risks may be more...

Cembra Money Bank has recently overhauled its organisation, creating a new Sales division, a Corporate Functions division and reshaping executive roles, including appointing a Chief Sales Officer and combining the CFO and Chief Risk Officer responsibilities. By consolidating core commercial activities and elevating compliance as an independent function, the bank is signalling a stronger push for integrated customer service while preserving an emphasis on risk and control. We’ll now examine...

How ABB stock has been trading recently The recent move in ABB (SWX:ABBN) has drawn attention after a mixed short term performance, with the stock down 1.3% over the past day and 4.3% over the past week. That pullback sits alongside a gain of 5% over the past month and a 16.3% rise over the past 3 months. The year to date return stands at 36.5%, and the 1 year total return at 78.4%. See our latest analysis for ABB. ABB’s recent share price pullback, with a 1 week share price return of 4.35%...

Logitech International (SWX:LOGN) has drawn fresh attention after Logitech G was named the Official PC Peripheral Partner for Call of Duty: Modern Warfare 4, tying the stock story directly to premium gaming accessories. See our latest analysis for Logitech International. While Logitech International’s latest gaming partnership has caught the headlines, the share price tells a mixed story. The 7 day share price return is 6.77% and the 30 day share price return is down 6.43%. This is set...

Banque Cantonale du Jura (SWX:BCJ) has just posted its H1 2026 scorecard, with total revenue for H2 2025 at CHF 32.7 million and net income excluding extraordinary items at CHF 3.3 million. These figures help set the tone for how investors may interpret the latest half-year results. The bank has reported revenue of CHF 31.4 million in H2 2024, CHF 37.1 million in H1 2025 and CHF 32.7 million in H2 2025, while trailing twelve month net income excluding extraordinary items is CHF 12.3 million...

Landis+Gyr Group (SWX:LAND) has drawn fresh attention after Benton Rural Electric Association agreed to deploy its Revelo platform and hybrid Gridstream Connect network, highlighting demand for the company’s advanced metering and grid-edge sensing solutions. See our latest analysis for Landis+Gyr Group. Despite the Benton REA win and recent AGM decisions on dividends, board changes and updated articles, Landis+Gyr Group’s share price return has been weak, with the stock down 16.3% over 30...

PSP Swiss Property (SWX:PSPN) has called a special investor meeting for 27 June 2026 to discuss a corporate transaction and revised EBITDA guidance, a combination that often signals meaningful implications for future cash flows. See our latest analysis for PSP Swiss Property. At a share price of CHF143.8, PSP Swiss Property has seen its 90 day share price return fall 9.04%, while the 1 year total shareholder return of 5.74% sits against a much stronger 3 year total shareholder return of...

UBS Group (SWX:UBSG) is back in focus after MSCI Inc. announced a partnership with the Swiss bank to expand an AI powered private markets platform that targets data fragmentation and transparency gaps. See our latest analysis for UBS Group. The MSCI partnership arrives at a time when UBS Group’s share price has climbed to CHF41.88, with a 30-day share price return of 10.44% and a 90-day share price return of 28.00%. The 1-year total shareholder return of 48.91% and 5-year total shareholder...

Cembra Money Bank (SWX:CMBN) has launched a new Sales division under Chief Sales Officer Peter Schnellmann and created a Corporate Functions division, reshaping its management structure while long serving executives prepare to depart. See our latest analysis for Cembra Money Bank. Cembra Money Bank’s latest management reshuffle lands after a period where momentum has softened, with the share price down 7.08% over 90 days and year to date, while the 3 year total shareholder return of 46.25%...

The European markets have shown resilience, with the STOXX Europe 600 Index rising by nearly 2% amid easing inflation concerns and positive economic indicators from major economies like Germany and France. Penny stocks, often associated with smaller or newer companies, continue to hold potential for investors who seek opportunities beyond the mainstream. By focusing on those with solid financial foundations and growth prospects, these stocks can offer a unique blend of value and potential...

Alcon (SWX:ALC) is back in focus after announcing a non exclusive collaboration with RxSight to co develop adjustable presbyopia correcting intraocular lenses, linking Alcon’s PCIOL designs with RxSight’s light adjustable technology. See our latest analysis for Alcon. Despite the RxSight collaboration bringing Alcon’s cataract technology back into the spotlight, the share price is still down about 11% over 90 days and the 1 year total shareholder return has fallen about 21%. This points to...

Nestlé (SWX:NESN) is back in focus after an infant formula recall prompted a reset in parts of the business, with the company leaning on healthcare outreach, AI driven product development and a cleaner-label shift. See our latest analysis for Nestlé. Nestlé’s recent infant formula reset, clean label commitments and push into AI supported product development appear to be coinciding with improving sentiment. The CHF85.12 share price has posted an 11.36% year to date share price return and a...

DKSH Holding (SWX:DKSH) has drawn fresh attention after DKSH Management Ltd. agreed to sell, promote, and distribute Eli Lilly’s pharmaceutical products in Hong Kong and Macau, expanding a collaboration already active in Singapore and Vietnam. See our latest analysis for DKSH Holding. DKSH Holding’s latest agreement with Eli Lilly comes as the stock shows building momentum, with an 11.53% 90 day share price return and a 10.58% year to date share price return, alongside a 5 year total...

Novartis (SWX:NOVN) has agreed to acquire UK based Myricx Bio, a privately held biotechnology company. Myricx Bio focuses on first in class N myristoyltransferase inhibitor (NMTi) antibody drug conjugate technology for cancer treatment. The deal adds a platform targeting HER2 and B7 H3 positive cancers, including certain treatment resistant tumors, to Novartis' oncology pipeline. For investors tracking large cap pharma, this move expands how Novartis is positioned within oncology, an area...

Logitech International S.A. recently announced it became the Official PC Peripheral Partner for Call of Duty: Modern Warfare 4, integrating Logitech G mice, keyboards, headsets, in-game items, and creator tools into the franchise’s ecosystem. The partnership extends beyond branding, tying Logitech G hardware, Streamlabs-powered creator experiences, and LIGHTSYNC RGB integrations directly into Modern Warfare 4’s “Play for Prestige” campaign, which could deepen gamer engagement with the...

Lonza Group (SWX:LONN) has been active on several fronts, with fresh agreements covering biologics manufacturing, central nervous system drug delivery research and antibody drug conjugate payload production capacity at its Visp site. See our latest analysis for Lonza Group. Lonza Group’s recent series of CNS partnerships, biologics expansions and ADC capacity investments has coincided with building momentum, with a 30-day share price return of 18.3% and a 1-year total shareholder return of...

In July 2026, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising by nearly 2% amid easing inflation concerns and stable unemployment rates. As investors navigate these conditions, growth companies with high insider ownership can present compelling opportunities due to their potential alignment of management interests with shareholders and the ability to capitalize on favorable economic developments.

As the pan-European STOXX Europe 600 Index recently advanced by 1.96%, bolstered by lower oil prices and easing inflation expectations, investor sentiment in Europe appears cautiously optimistic. In this environment, identifying undervalued stocks becomes crucial, as these opportunities may offer potential for growth when market conditions stabilize further.

Client win puts Bachem Holding in focus ImmuPharma PLC has appointed Bachem Holding (SWX:BANB) subsidiary Bachem AG to manufacture the active pharmaceutical ingredient for its Kapiglucagon program, marking a key Chemistry, Manufacturing and Controls milestone for the project. The collaboration positions Bachem Holding within the next stage of Kapiglucagon development, with work initially centered on the active ingredient before ImmuPharma selects a separate partner for drug product...

SGS (SWX:SGSN) has launched SGS Compass, a cloud and AI driven platform aimed at tightening supplier risk management, compliance and sustainability across complex global supply chains for corporate and institutional clients. See our latest analysis for SGS. The launch of SGS Compass comes as SGS shares trade at CHF95.30, with a 30 day share price return of 6.53% and a 90 day share price return of 15.35%. The 1 year total shareholder return of 19.12% contrasts with a 5 year total shareholder...